Johnson & Johnson subsidiary Ethicon announced today that it will cease marketing most of its vaginal mesh products. This announcement was made in two letters sent to the judges who are coordinating the Federal Multi-District Transvaginal Mesh Litigation in West Virginia, and in the coordinated New Jersey State Court Litigation. The company will be informing physicians to use alternative treatment. Ethicon also asked for a label chance for its Gynemesh PS product, making it only available to be used abdominally to treat pelvic organ prolapse. We believe this action came too late, and many women were unnecessarily injured by a defective implant which they should have never received. It was a year ago when the FDA warned of the risks of protrusion through the vaginal tissue, pain, infection and other injuries. I expect there to be thousands of vaginal mesh injury lawsuits filed throughout the United States. This withdrawal, and all of the evidence which led to it, should play a large role in driving vaginal mesh settlements providing compensation for victims of this defective medical device.